Aveanna Healthcare Raises FY2025 Guidance and Provides Initial FY2026 Outlook

summarizeSummary

Aveanna Healthcare Holdings, Inc. announced updated full-year 2025 guidance, raising revenue and Adjusted EBITDA expectations, and provided initial full-year 2026 guidance.

check_boxKey Events

• Updated FY2025 Revenue Guidance

  The company raised its full-year 2025 revenue guidance to a range of $2.425 billion to $2.445 billion, up from its previous expectation of greater than $2.375 billion.

• Updated FY2025 Adjusted EBITDA Guidance

  Aveanna increased its full-year 2025 Adjusted EBITDA guidance to a range of $318 million to $322 million, an increase from its prior guidance of greater than $300 million.

• Initial FY2026 Guidance Provided

  For fiscal year 2026, the company expects revenue between $2.54 billion and $2.56 billion, and Adjusted EBITDA between $318 million and $322 million.

auto_awesomeAnalysis

Aveanna Healthcare Holdings, Inc. has updated its financial outlook, raising its full-year 2025 revenue and Adjusted EBITDA guidance. This positive revision suggests stronger performance than previously anticipated for the current fiscal year. Additionally, the company provided its initial full-year 2026 guidance, offering investors a forward-looking perspective on its expected financial trajectory. The increased guidance for 2025 indicates operational strength and could lead to positive market sentiment.